Puts Sold on Keryx Biopharma (KERX)

Shares of Keryx Biopharmaceuticals KERX are higher on the session by 3.43%, currently trading at $3.62. The stock has been trading largely lower over the past three months, off from its highs near $6.70, which were reached during the ASCO conference. Options traders are selling puts on the name today. The August $2.50 put was sold 3,000 times, on the bid, for $0.10; open interest on the strike was only 10 contracts. The September $2.50 put was also sold, 2,000 times on the bid, for $0.20. Put volume is now running at 18.5x the daily average. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease